Showing results (1171-1180 of 1,354) with videos related to
Sort By:
Pageof 136
Biology|March 6, 2021
A Stress Syndrome Prototype Reflects Type 3 Diabetes and Ischemic Stroke Risk: The SABPA StudyLeoné Malan, Mark Hamer, Roland von Känel, et al.Cancer Research|January 10, 2019
HER2 CAR-T Cells Eradicate Uveal Melanoma and T-cell Therapy-Resistant Human Melanoma in IL2 Transgenic NOD/SCID IL2 Receptor Knockout MiceElin M V Forsberg, Mattias F Lindberg, Henrik Jespersen, et al.Climacteric : the Journal of the International Menopause Society|June 13, 2006
Evidence for associations between common polymorphisms of estrogen receptor beta gene with homocysteine and nitric oxideM Reimann, K Vafeiadou, W L Hall, et al.BMJ (Clinical Research Ed.)|April 19, 2013
Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control studyAndrew J Vickers, David Ulmert, Daniel D Sjoberg, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 20, 2016
A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junctionF Klevebro, G Alexandersson von Döbeln, N Wang, et al.European Journal of Preventive Cardiology|June 24, 2017
Single and multiple cardiovascular biomarkers in subjects without a previous cardiovascular eventManan Pareek, Deepak L Bhatt, Muthiah Vaduganathan, et al.Cancer Cell|May 17, 2005
Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formationJonas A Nilsson, Ulrich B Keller, Troy A Baudino, et al.Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|August 24, 2018
Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or gastroesophageal junction: long-term results of a randomized clinical trialG A von Döbeln, F Klevebro, A-B Jacobsen, et al.Cancers|February 11, 2023
Treatment with Anti-HER2 Chimeric Antigen Receptor Tumor-Infiltrating Lymphocytes (CAR-TILs) Is Safe and Associated with Antitumor Efficacy in Mice and Companion DogsElin M V Forsberg, Rebecca Riise, Sara Saellström, et al.Cardiovascular Diabetology|July 2, 2022
Galectin-4 levels in hospitalized versus non-hospitalized subjects with obesity: the Malmö Preventive ProjectJohan Korduner, Hannes Holm, Amra Jujic, et al.Pageof 136